Industry News: CEI Ventures, Inc., a community development venture capital firm based in Maine, has joined a $25 million funding round in Galatea Bio, a Miami-based biotechnology company transforming genomic research that represent diverse population ancestries and is revolutionizing precision medicine. Galatea is building the world’s largest biobank focused on non-European populations to drive more inclusive biomarker discovery, diagnostics, and drug development. By combining AI-powered analytics with large-scale genomic data, the company is creating ancestry-aware tools for disease modeling and risk assessment, expanding access to equitable healthcare for all. This funding will support the growth of the Galatea Global Biobank, further Galatea’s mission to advance personalized medicine for underserved communities worldwide and will create employment opportunities in the Miami community. CEI Ventures, Inc. is a subsidiary of Coastal Enterprises, a CDVCA member fund and an investee of CDVCA’s Central Fund. For more information, visit CEI Ventures, Inc. and Galatea.bio.
